Physician

Romulo Jc Albuquerque, MD

According to 2025 Medicare claims, Romulo Albuquerque, MD (NPI: 1265726905) practices ophthalmology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is VISTAR EYE CENTER, INC (NPI: 1457323545; TIN: 540853078) and primary practice location at 24019-3813.

Albuquerque's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,032 traditional Medicare patients, billed 104,130 HCPCS/CPT codes, and received $4,050,321 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 495 prescription claims across 193 beneficiaries totaling $15,695 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 40 records totaling $3,856. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,532 to $4,050,321. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $4,210 to $15,695. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.1M2016 Medicare payment: $9,532 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $35,691 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $102,010 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $609,735 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,050,358 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,669,158 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,763,461 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,870,123 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,050,321 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20165663$9,532
2017127349$35,691
20181941,559$102,010
20194553,916$609,735
20207679,818$2,050,358
202186511,750$2,669,158
20221,00122,402$3,763,461
20231,02666,114$3,870,123
20241,032104,130$4,050,321

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$25K2015 Drug cost: $4,210 (USD; Tot_Drug_Cst)2016 Drug cost: $1,616 (USD; Tot_Drug_Cst)2017 Drug cost: $3,272 (USD; Tot_Drug_Cst)2018 Drug cost: $3,067 (USD; Tot_Drug_Cst)2019 Drug cost: $8,432 (USD; Tot_Drug_Cst)2020 Drug cost: $25,089 (USD; Tot_Drug_Cst)2021 Drug cost: $18,611 (USD; Tot_Drug_Cst)2022 Drug cost: $15,530 (USD; Tot_Drug_Cst)2023 Drug cost: $14,695 (USD; Tot_Drug_Cst)2024 Drug cost: $15,695 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151859$4,210
20162034$1,616
20172558$3,272
20182650$3,067
201973134$8,432
2020144338$25,089
2021159345$18,611
2022184396$15,530
2023164378$14,695
2024193495$15,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye166167$119
67028Injection of drug into eye4551,777$91
92014Established patient complete exam of visual system8731,599$82
92134Imaging of retina9952,820$28
J2777Injection, faricimab-svoa, 0.1 mg30593,060$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1664,001$4,588
DifluprednateDifluprednate38853$4,148
CombiganBrimonidine Tartrate/Timolol11323$2,062
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol15494$1,002
OfloxacinOfloxacin861,953$914

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$3,856Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Romulo Jc Albuquerque, MD?

Tedicare shows public-source Medicare data for Romulo Jc Albuquerque, MD (NPI 1265726905), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Romulo Jc Albuquerque, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Romulo Jc Albuquerque, MD?

Romulo Jc Albuquerque, MD is linked to VISTAR EYE CENTER, INC (billing NPI 1457323545) in the available physician profile data.

Does Romulo Jc Albuquerque, MD have Open Payments data?

Romulo Jc Albuquerque, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.